Latest Kidney transplantation Stories

With the help of GiveForward.com, one family has launched a campaign to help Cindy, a single mother in dialysis, who is in great need of help. Miami, Fl (PRWEB) December 08, 2012 The Holiday Season is a special time to reflect and focus on the things and the people we are most thankful for. For many, their own health and the wellbeing of those around them are of the upmost importance. Having those things in tact often means much more than receiving a grand holiday present. Unfortunately,...

HORSHOLM, Denmark, Dec. 6, 2012 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) today announced results of a preliminary analysis from the first 16 patients in its Switching STudy of Kidney TRansplant PAtients with Tremor to LCP-TacrO (STRATO) clinical trial. Results from the first 16 patients demonstrated a trend toward a reduction in tremor following the switch from twice-daily tacrolimus to once-daily LCP-Tacro. "Tremor is a common side effect of tacrolimus administration...

Kidney Community Urges Congress to Prevent Additional Cuts to Medicare Dialysis Benefit, Vulnerable Patients' Care During Fiscal Cliff Discussions WASHINGTON, Dec. 5, 2012 /PRNewswire-USNewswire/ -- Seven-time NBA All-Star Alonzo Mourning joined with representatives of Kidney Care Partners (KCP), a broad-based coalition and leading voice of the kidney community, on Capitol Hill today to announce significant improvements in patient care outcomes and urge Congress to maintain its...

NORTHBROOK, Ill., Dec. 4, 2012 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas"), a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the company's New Drug Application (NDA) for tacrolimus extended release capsules, for the prophylaxis of organ rejection in adult kidney transplant recipients and adult male liver transplant recipients. Based upon the September receipt of the...

Findings could help provide better donor-recipient matches and tailor recipients' treatments after kidney transplantation Highlights: -The detection of preformed donor-specific antibodies by newer tests, despite negative results from traditional tests, nearly doubles a kidney transplant recipient's risk for rejection. -It also increases the risk of kidney failure by 76%. Nearly 17,000 kidney transplants take place each year in the United States. Kidney transplant recipients who...

WINSTON-SALEM, N.C., Nov. 13, 2012 /PRNewswire/ -- Tengion, Inc. (OTCQB: TNGN), a leader in regenerative medicine, today reported its financial results for the third quarter ended September 30, 2012 and provided a business update. "We are focused on enrolling the remaining four patients in the Phase 1 trial of our Neo-Urinary Conduit, which we hope to complete by year-end, and we are working aggressively to file the IND for our Neo-Kidney Augment during the first half of 2013,"...

In one of the largest and longest trials involving patients with kidney failure, a study led by an international team of researchers found that cinacalcet — a drug commonly prescribed to patients with kidney failure and a disturbance of bone and mineral metabolism known as secondary hyperparathyroidism — does not significantly reduce the risk of death or major cardiovascular events. The results of the trial known as EVOLVE, which enrolled nearly 4,000 kidney patients from several...

Developing 'comorbid' conditions post-transplant reduces donor quality of life Researchers in Japan report that health-related quality of life (HRQOL) for donors following living donor liver transplantation (LDLT) was better than the general Japanese population (the norm). This study—one of the largest to date—found that donors who developed two or more medical problems (co-morbidities) after donation had significantly decreased long-term HRQOL. Full findings are published in the...

Largest living donor kidney transplant program in the country reaches milestone CHICAGO, Oct. 23, 2012 /PRNewswire-USNewswire/ -- Northwestern Medicine® transplant surgeons and physicians have reached a significant milestone with the completion of the 100th successful kidney paired donation transplant, a strategy which has enlarged the pool of kidneys available for donation for patients with a living donor who is not compatible. "We are proud of this accomplishment and our...

Active surveillance of small kidney masses is a safe and effective alternative to immediate surgery, with similar overall and cancer specific survival rates, according to a study published in the November issue of the urology journal BJUI. The technique is primarily used to treat elderly patients who have complex health issues or decline surgery. But researchers from the Department of Urology at Churchill Hospital, Oxford, UK, say that the results of their study suggest that active...